• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-223 在肝脏疾病中的调控作用及治疗靶点

MiR-223 as a Regulator and Therapeutic Target in Liver Diseases.

机构信息

School of Medicine, Ningbo University, Ningbo, China.

The Affiliated Hospital of Medical School, Ningbo University, Ningbo, China.

出版信息

Front Immunol. 2022 Mar 16;13:860661. doi: 10.3389/fimmu.2022.860661. eCollection 2022.

DOI:10.3389/fimmu.2022.860661
PMID:35371024
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8965842/
Abstract

MicroRNAs (miRNAs) are endogenous non-coding single-stranded small molecule RNAs consisting of 20-24 nucleotides that are highly conserved in species evolution. Expression of miRNAs is strictly tissue-specific, and it is chronological in fungi and plants, as well as in animals. MiR-223 has been shown to play a key role in innate immunity, and dysregulation of its expression contributes to the pathogenesis of multiple inflammatory diseases, and cancers. In this article the biosynthesis and functions of miR-223 in innate immunity are reviewed, and the role of miR-223 in liver physiopathology and therapeutic prospects are highlighted.

摘要

微小 RNA(miRNAs)是内源性非编码单链小分子 RNA,由 20-24 个核苷酸组成,在物种进化中高度保守。miRNAs 的表达具有严格的组织特异性,在真菌和植物以及动物中具有时间特异性。已经证明 miR-223 在先天免疫中发挥关键作用,其表达的失调导致多种炎症性疾病和癌症的发病机制。本文综述了 miR-223 在先天免疫中的生物合成和功能,并强调了 miR-223 在肝脏生理病理和治疗前景中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf01/8965842/20f26dad8fb0/fimmu-13-860661-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf01/8965842/308fa9c987c8/fimmu-13-860661-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf01/8965842/9ae5ad6c011e/fimmu-13-860661-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf01/8965842/e5c47fd0b0e0/fimmu-13-860661-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf01/8965842/1768c606352b/fimmu-13-860661-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf01/8965842/20f26dad8fb0/fimmu-13-860661-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf01/8965842/308fa9c987c8/fimmu-13-860661-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf01/8965842/9ae5ad6c011e/fimmu-13-860661-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf01/8965842/e5c47fd0b0e0/fimmu-13-860661-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf01/8965842/1768c606352b/fimmu-13-860661-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf01/8965842/20f26dad8fb0/fimmu-13-860661-g005.jpg

相似文献

1
MiR-223 as a Regulator and Therapeutic Target in Liver Diseases.miR-223 在肝脏疾病中的调控作用及治疗靶点
Front Immunol. 2022 Mar 16;13:860661. doi: 10.3389/fimmu.2022.860661. eCollection 2022.
2
Role of miR-223 in the pathophysiology of liver diseases.miR-223 在肝脏疾病病理生理学中的作用。
Exp Mol Med. 2018 Sep 26;50(9):1-12. doi: 10.1038/s12276-018-0153-7.
3
MicroRNA miR-223 as regulator of innate immunity.miR-223 作为先天免疫的调节因子。
J Leukoc Biol. 2018 Sep;104(3):515-524. doi: 10.1002/JLB.3MR0218-079R. Epub 2018 Jul 3.
4
MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases.微小 RNA 作为肝脏疾病的调控因子、生物标志物和治疗靶点。
Gut. 2021 Apr;70(4):784-795. doi: 10.1136/gutjnl-2020-322526. Epub 2020 Oct 30.
5
MiR-146 and miR-125 in the regulation of innate immunity and inflammation.微小RNA-146和微小RNA-125在先天性免疫和炎症调节中的作用
BMB Rep. 2016 Jun;49(6):311-8. doi: 10.5483/bmbrep.2016.49.6.056.
6
Role of microRNA-7 in liver diseases: a comprehensive review of the mechanisms and therapeutic applications.miR-7 在肝脏疾病中的作用:机制和治疗应用的综合综述。
J Investig Med. 2020 Oct;68(7):1208-1216. doi: 10.1136/jim-2020-001420. Epub 2020 Aug 24.
7
MicroRNAs, innate immunity and ventricular rupture in human myocardial infarction.微小 RNA、先天免疫与人类心肌梗死的心室破裂。
Dis Markers. 2011;31(5):259-65. doi: 10.3233/DMA-2011-0827.
8
Profiling microRNA expression in bovine alveolar macrophages using RNA-seq.利用RNA测序分析牛肺泡巨噬细胞中的微小RNA表达
Vet Immunol Immunopathol. 2013 Oct 1;155(4):238-44. doi: 10.1016/j.vetimm.2013.08.004. Epub 2013 Aug 24.
9
The microRNAs miR-302b and miR-372 regulate mitochondrial metabolism via the SLC25A12 transporter, which controls MAVS-mediated antiviral innate immunity.微小RNA miR-302b和miR-372通过SLC25A12转运蛋白调节线粒体代谢,该转运蛋白控制MAVS介导的抗病毒天然免疫。
J Biol Chem. 2020 Jan 10;295(2):444-457. doi: 10.1074/jbc.RA119.010511. Epub 2019 Nov 25.
10
MicroRNAs involved in innate immunity regulation in the sea cucumber: A review.参与海参固有免疫调节的 microRNAs:综述。
Fish Shellfish Immunol. 2019 Dec;95:297-304. doi: 10.1016/j.fsi.2019.10.049. Epub 2019 Oct 25.

引用本文的文献

1
MicroRNAs in Liver Cirrhosis: Diagnostic and Therapeutic Perspectives-A Comprehensive Review.肝硬化中的微小RNA:诊断与治疗前景——一篇综述
J Pers Med. 2025 Aug 14;15(8):376. doi: 10.3390/jpm15080376.
2
lncRNA RP11-34D15.2 sponges miR-223 to promote the PGC-1α/irisin signaling pathway, contributing to increased FFA and insulin resistance in obese children.长链非编码RNA RP11-34D15.2通过吸附微小RNA-223来促进PGC-1α/鸢尾素信号通路,导致肥胖儿童游离脂肪酸增加和胰岛素抵抗。
Endocr Connect. 2025 Jun 10;14(6). doi: 10.1530/EC-25-0028. Print 2025 Jun 1.
3
RNA-Sequencing Reveals the Modulation of the NLRP3 Inflammasome by miR-223-3p in Extracellular Vesicles in Bacterial Endophthalmitis.

本文引用的文献

1
miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions.miRTarBase 更新 2022:一个经过实验验证的 miRNA-靶标相互作用的信息资源。
Nucleic Acids Res. 2022 Jan 7;50(D1):D222-D230. doi: 10.1093/nar/gkab1079.
2
miRNA-223 Suppresses Mouse Gallstone Formation by Targeting Key Transporters in Hepatobiliary Cholesterol Secretion Pathway.miRNA-223 通过靶向肝胆胆固醇分泌途径中的关键转运蛋白抑制小鼠胆石形成。
Int J Biol Sci. 2021 Oct 25;17(15):4459-4473. doi: 10.7150/ijbs.65485. eCollection 2021.
3
Hepatocyte-Specific Deficiency of BAP31 Amplified Acetaminophen-Induced Hepatotoxicity via Attenuating Nrf2 Signaling Activation in Mice.
RNA测序揭示了细菌性眼内炎细胞外囊泡中miR-223-3p对NLRP3炎性小体的调控作用。
Invest Ophthalmol Vis Sci. 2025 Apr 1;66(4):53. doi: 10.1167/iovs.66.4.53.
4
Bioinformatics analysis and experimental validation of potential targets and pathways in chronic kidney disease associated with renal fibrosis.慢性肾脏病相关肾纤维化潜在靶点及通路的生物信息学分析与实验验证
J Transl Med. 2025 Apr 2;23(1):387. doi: 10.1186/s12967-024-06058-x.
5
Non-coding RNAs: emerging biomarkers and therapeutic targets in cancer and inflammatory diseases.非编码RNA:癌症和炎症性疾病中新兴的生物标志物及治疗靶点
Front Oncol. 2025 Mar 10;15:1534862. doi: 10.3389/fonc.2025.1534862. eCollection 2025.
6
Myeloid-derived MANF ameliorates ethanol-induced liver injury by enhancing microRNA-223 expression.髓源性MANF通过增强微小RNA-223的表达改善乙醇诱导的肝损伤。
J Gastroenterol. 2025 Mar 20. doi: 10.1007/s00535-025-02240-0.
7
miR-223 and Chromogranin A Affect Inflammatory Immune Cell Activation in Liver Metastasis of Neuroendocrine Neoplasms.微小RNA-223和嗜铬粒蛋白A影响神经内分泌肿瘤肝转移中的炎性免疫细胞活化
Cells. 2025 Jan 14;14(2):111. doi: 10.3390/cells14020111.
8
MicroRNA Significance in Cancer: An Updated Review on Diagnostic, Prognostic, and Therapeutic Perspectives.微小RNA在癌症中的意义:关于诊断、预后和治疗前景的最新综述
EJIFCC. 2024 Dec 30;35(4):265-284. eCollection 2024 Dec.
9
The modulation of immune cell death in connection to microRNAs and natural products.与微小RNA和天然产物相关的免疫细胞死亡调节
Front Immunol. 2024 Dec 20;15:1425602. doi: 10.3389/fimmu.2024.1425602. eCollection 2024.
10
MicroRNA-206 as a promising epigenetic approach to modulate tumor-associated macrophages in hepatocellular carcinoma.miRNA-206 作为一种有前途的表观遗传方法,可调节肝癌中的肿瘤相关巨噬细胞。
World J Gastroenterol. 2024 Nov 7;30(41):4503-4508. doi: 10.3748/wjg.v30.i41.4503.
BAP31 特异性敲除肝细胞加剧对乙酰氨基酚诱导的肝毒性损伤及其机制研究。
Int J Mol Sci. 2021 Oct 5;22(19):10788. doi: 10.3390/ijms221910788.
4
Aging exaggerates acute-on-chronic alcohol-induced liver injury in mice and humans by inhibiting neutrophilic sirtuin 1-C/EBPα-miRNA-223 axis.衰老通过抑制中性粒细胞 SIRT1-C/EBPα-miRNA-223 轴加剧小鼠和人类的急慢性酒精性肝损伤。
Hepatology. 2022 Mar;75(3):646-660. doi: 10.1002/hep.32152. Epub 2021 Dec 5.
5
MicroRNA-223 modulates the IL-4-medicated macrophage M2-type polarization to control the progress of sepsis.MicroRNA-223 调节 IL-4 介导的巨噬细胞 M2 型极化以控制脓毒症的进展。
Int Immunopharmacol. 2021 Jul;96:107783. doi: 10.1016/j.intimp.2021.107783. Epub 2021 Jun 1.
6
Epithelium- and endothelium-derived exosomes regulate the alveolar macrophages by targeting RGS1 mediated calcium signaling-dependent immune response.上皮细胞和内皮细胞衍生的外泌体通过靶向 RGS1 介导的钙信号依赖性免疫反应调节肺泡巨噬细胞。
Cell Death Differ. 2021 Jul;28(7):2238-2256. doi: 10.1038/s41418-021-00750-x. Epub 2021 Mar 22.
7
The inflammatory kinase IKKα phosphorylates and stabilizes c-Myc and enhances its activity.炎症激酶IKKα使c-Myc磷酸化并使其稳定,增强其活性。
Mol Cancer. 2021 Jan 18;20(1):16. doi: 10.1186/s12943-021-01308-8.
8
Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis.中性粒细胞-肝细胞通过 LDLR 依赖性 miR-223 富集的细胞外囊泡转移的通讯改善非酒精性脂肪性肝炎。
J Clin Invest. 2021 Feb 1;131(3). doi: 10.1172/JCI141513.
9
Myeloid-Cell-Specific IL-6 Signaling Promotes MicroRNA-223-Enriched Exosome Production to Attenuate NAFLD-Associated Fibrosis.髓系细胞特异性 IL-6 信号促进富含 microRNA-223 的外泌体产生,从而减轻非酒精性脂肪性肝病相关纤维化。
Hepatology. 2021 Jul;74(1):116-132. doi: 10.1002/hep.31658. Epub 2021 Apr 27.
10
MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases.微小 RNA 作为肝脏疾病的调控因子、生物标志物和治疗靶点。
Gut. 2021 Apr;70(4):784-795. doi: 10.1136/gutjnl-2020-322526. Epub 2020 Oct 30.